Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history
Dual-listed across the NASDAQ and ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GBI | Ann: Removal from Official List - Annual Listing Fees | 29/08/19 | 0 | 1.1K | |||
|
|||||||
GBI | Ann: Suspension from Official Quotation - Annual Listing Fee | 25/08/19 | 1 | 1.4K | |||
|
|||||||
GBI | Ann: Final Director's Interest Notice | 21/08/19 | 0 | 726 | |||
|
|||||||
GBI | News: GBI Genera Biosystems Says Damian Pethica Resigned As Executive Chairman | 20/08/19 | 0 | 639 | |||
|
|||||||
GBI | Ann: Resignation of Executive Director and Company Secretary | 20/08/19 | 0 | 635 | |||
|
|||||||
GBI | News: GBI Genera Biosystems Intends To Undertake Capital Raise | 31/07/19 | 0 | 778 | |||
|
|||||||
GBI | Ann: Appendix 4C Quarterly Cash Flow and Business Update | 31/07/19 | 0 | 796 | |||
|
|||||||
GBI | Ann: Appendix 3B | 25/07/19 | 0 | 445 | |||
|
See All Discussions